Effect of pioglitazone treatment in a patient with secondary multiple sclerosis

BACKGROUND: Ligands of the peroxisome proliferator-activated receptor-gamma (PPARγ) induce apoptosis in activated T-lymphocytes and exert anti-inflammatory effects in glial cells. Preclinical studies have shown that the thiazolidinedione pioglitazone, an FDA-approved PPARγ agonist used to treat type...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Pershadsingh, Harrihar A, Heneka, Michael T, Saini, Rashmi, Amin, Navin M, Broeske, Daniel J, Feinstein, Douglas L
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2004
Pynciau:
Case Report
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC483056/
https://ncbi.nlm.nih.gov/pubmed/15285799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-2094-1-3
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg